 鲜花( 85)  鸡蛋( 2)
|
楼主 |
发表于 2015-2-28 21:48
|
显示全部楼层
Stock soars after Cold-fX wins crucial approval
$ c, v4 h; ^( W& D# d9 s0 h- |
" Q7 P D, F+ r- X5 D& Z+ R0 ?3 vEDMONTON - CV Technologies Inc. shares rose nearly 60 per cent Thursday after Health Canada approved the claims at the core of the company's marketing of its cold and flu drug Cold-fX.
4 X& L8 ?5 M. } / h6 f, H7 b; V5 S/ u, N2 I$ {
BY THE EDMONTON JOURNAL FEBRUARY 16, 2007
* T& f+ S7 _7 E
' J9 u% B, G/ Y$ E3 k$ Y( [
" z! N* h, R% W0 ZEDMONTON - CV Technologies Inc. SHARES rose nearly 60 per cent Thursday after Health Canada approved the claims at the core of the company's marketing of its cold and flu drug Cold-fX.2 @% E( V4 ]# \% s5 `6 ]$ U
0 ^8 [ o" Q' D6 u
The agency said CV Technologies can continue to market Cold-fX as helping "to reduce the frequency, severity and duration of cold and flu symptoms by boosting the IMMUNE SYSTEM.": {0 X. O$ M9 M% V
+ ^1 z) H' L( p. [+ p" O
The APPROVAL follows a review of seven clinical trials and more than 10 years of research about the product.
2 h' f# b9 K5 U0 T! G D: j
9 L- c r a4 _0 g$ i+ XIt should create even more confidence among consumers and medical professionals that the product works, CEO Jacqueline Shan said Thursday.
/ o) Z! g l) F g {5 x$ m$ f5 l
- { r( ]( S, h4 qIt certainly instilled confidence in the market, as shares closed at $2.90 on THE TORONTO STOCK EXCHANGE, up $1.08 on a volume of 4.6 million.6 B: {2 a4 r& r
, V3 t$ H% L! x" i9 H
"As a scientist, it's one of the highlights of my CAREER," Shan said.
, r# `0 u9 p/ H% H" }( w) j
0 I( b# e% ~3 u4 _6 a2 i" I; l"This approval is a breakthrough in realizing our vision of being a global leader in developing products for disease prevention."
" I e( n# B0 B; h* o
4 W7 m" v" E/ |, n, \) }! QIt's Cold-fX's strongest medical recognition to date, said Shan. It means the company can advertise the HEALTH BENEFITS more effectively to consumers and health professionals, she said.9 i3 P* }. g7 S; p7 F! l5 s
7 @+ T2 H# B& y7 a- NGinseng-based Cold-fX is already the top-selling cold and flu treatment in Canada, but Shan said there is plenty of room for more growth.
/ b" V. `# i" k J! z0 v+ [, ?
1 S0 a" E4 b4 V1 [ {/ MThe approval will also help raise the product's PROFILE in the lucrative U.S. market, which Cold-fX entered in October. The move came with a new marketing push, using former Oilers superstar Mark Messier as its spokesman.
/ E& S5 t$ {$ p# g* G8 r
% R4 j$ q. T6 i2 M7 L; {3 }$ O0 V, H# S, S
http://www.canada.com/story.html ... 9-be80-f40f1426f662 |
|
狗仔卡
发表于 2015-2-28 18:25
提升卡
置顶卡
沉默卡
喧嚣卡
变色卡
显身卡
发表于 2015-2-28 19:45
